Regeneron Pharmaceuticals, Inc.

GOLDMAN SACHS GROUP INC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

1,097,327

Value ($000)

846,994

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	846,994	0.1%	1,097,327	12/31/2025
2025 Q3	11/14/2025	535,753	0.1%	952,839	9/30/2025
2025 Q2	8/14/2025	418,008	0.1%	796,206	6/30/2025
2025 Q1	6/27/2025	530,910	0.1%	837,093	3/31/2025
2024 Q4	2/11/2025	459,195	0.1%	644,637	12/31/2024
2024 Q3	11/14/2024	640,250	0.1%	609,043	9/30/2024
2024 Q2	8/13/2024	723,717	0.1%	688,579	6/30/2024
2024 Q1	5/15/2024	366,632	0.1%	380,921	3/31/2024
2023 Q4	5/14/2024	326,536	0.1%	371,785	12/31/2023
2023 Q3	5/15/2024	323,564	0.1%	393,170	9/30/2023
2023 Q2	5/14/2024	360,729	0.1%	502,030	6/30/2023
2023 Q1	5/14/2024	358,066	0.1%	435,778	3/31/2023
2022 Q4	5/14/2024	405,986	0.1%	562,705	12/31/2022
2022 Q3	5/14/2024	297,532	0.1%	431,915	9/30/2022
2022 Q2	5/14/2024	245,392	0.1%	415,125	6/30/2022
2022 Q1	5/16/2022	263,685	0.1%	377,547	3/31/2022
2021 Q4	2/17/2022	237,227	0.1%	375,645	12/31/2021
2021 Q3	1/20/2022	274,022	0.1%	452,792	9/30/2021
2021 Q2	8/13/2021	199,134	0.1%	356,525	6/30/2021
2021 Q1	5/17/2021	171,621	0.1%	362,728	3/31/2021
2020 Q4	2/12/2021	113,403	0.0%	234,734	12/31/2020
2020 Q3	11/13/2020	300,571	0.1%	536,944	9/30/2020
2020 Q2	8/12/2020	334,839	0.1%	536,903	6/30/2020
2020 Q1	5/15/2020	253,431	0.1%	519,017	3/31/2020
2019 Q4	2/14/2020	254,709	0.1%	678,356	12/31/2019
2014 Q1	5/15/2014	317,934	0.1%	1,058,790	3/31/2014
2013 Q4	2/14/2014	350,481	0.2%	1,273,364	12/31/2013